Bengaluru: Prime Minister Narendra Modi on Sunday said his government will soon launch a skill development programme for young Indians seeking jobs abroad.”We will shortly launch a skill development programme, the Pravasi Kaushal Vikas Yojana, targeted at Indian youth seeking overseas employment,” the Prime Minister said at the Pravasi Bharatiya Diwas 2017.Modi flashed a PIO (Person of Indian origin) card to say it supersedes the individual’s passport — as far as his ties to India are concerned.
When the PIO card is seen, “we don’t see the colour of the passport but the blood ties”, Modi said to huge applause.Referring to Mahatma Gandhi’s return from South Africa, Modi said this day marked the return to India of one of the greatest Pravasis and that his government’s priority was to convert “brain drain” into brain gain”.”NRIs and PIO have made outstanding contributions. Among them are politicians of great stature, scientists of repute, outstanding doctors, brilliant educationists, economists, journalists, musicians, engineers, bankers and did I mention our well known technology professionals,” Modi said.
From today India to export COVID-19 vaccines to these countries.
The Ministry of External Affairs said India will supply COVID-19 vaccines to partner countries over the coming weeks and months in a phased manner keeping in view the domestic requirements.
India, one of the world’s leading drug makers, will start exporting vaccines for the novel coronavirus from today. The country will provide supplies of Covid-19 vaccines to Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles under grant assistance. Shipments will be sent to Sri Lanka, Afghanistan and Mauritius as well on receipt of necessary regulatory clearances.
In a tweet, Prime Minister Narendra Modi said India is deeply honored to be a “long-trusted” partner in meeting the healthcare needs of the global community and that supplies of the vaccines to several countries will commence on Wednesday, and more will follow in the days ahead.
“In response to these requests, and in keeping with India’s stated commitment to using India’s vaccine production and delivery capacity to help all of the humanity fight the COVID pandemic, supplies under grant assistance to Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles will begin from January 20,” it said.
The Bangladesh foreign ministry said it expected to receive a gift of two million doses on Thursday. The country of 160 million, which has yet to start its vaccination programme, has ordered a further 30 million doses, officials said.
The Oxford/AstraZeneca vaccine is widely viewed as their best option because the other two, manufactured by Pfizer/BioNTech and by Moderna, need to be stored at very low temperatures. WHO emergency authorization for the Astra-Oxford vaccine would additionally allow SII to begin supplying it to the WHO-backed COVAX initiative aimed at fairly distributing COVID-19 shots across the world.
India has already rolled out a massive coronavirus vaccination drive under which two vaccines, Covishield and Covaxin, are being administered to frontline health workers across the country. While Oxford-AstraZeneca’s Covishield is being manufactured by the Serum Institute, Covaxin is being produced by Bharat Biotech.
“In an ongoing effort, India will continue to supply countries all over the world with vaccines. This will be calibrated against domestic requirements and international demand and obligations, including under GAVI’s Covax facility to developing countries,” the MEA added. GAVI is a global vaccine alliance.